Thanks to ObamaCare, you can now see how much money your doctor gets from drugmakers
Earlier this week, with little fanfare, the Department of Health and Human Services (HHS) released a public database of information about how much money and in-kind benefits doctors have been receiving from pharmaceutical and medical device makers. Only gifts of $10 or more are counted.
The Open Payments database — a requirement of the 2010 Affordable Care Act, or ObamaCare — is incomplete, with data from only the last five months of 2013 so far. But the numbers aren't small: From August to December, 546,000 Doctors, dentists, podiatrists, optometrists, and chiropractors plus 1,360 teaching hospitals received more than $3.48 billion in cash, gifts and in-kind services, stock options, and research grants from drugmakers and device makers. HHS is still verifying 300,000 records it didn't include in the database, so the total amount will rise. The biggest spenders so far are Genetech, Pfizer, and DePuy Synthes.
The idea is that, once the database is fully functional, patients and other interested parties will be able to see a doctor's financial ties to companies, so they can evaluate a doctor's treatments and — more importantly — to discourage conflicts of interest. The American Medical Association opposes the database, arguing that the numbers are out of context and potentially misleading, but this part of ObamaCare has bipartisan support.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
After a day or so of digging through the numbers, The New York Times has some of the biggest recipients — the typical doctor received $1,750 in those five months, but at least 130 named doctors pulled in more than $100,000 — and some of the largest potential conflicts of interest. If you're interested in a broader look at where the pharmaceutical/device money comes from and goes to, ProPublica has been tracking the cash for four years.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Today's political cartoons - October 13, 2024
Sunday's cartoons - the swing of things, fear of facts, and more
By The Week US Published
-
5 timely cartoons about climate change denial
Cartoons Artists take on textbook trouble, bizarre beliefs, and more
By The Week US Published
-
Kris Kristofferson: the free-spirited country music star who studied at Oxford
In the Spotlight The songwriter, singer and film-star has died aged 88
By The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published